Effect of sera from patients with sarcoidosis on in vitro lymphocyte response.
D000946:Antigens, Fungal; D000956:Antigens, Viral; D002175:Candida / Q000276:immunology; D002478:Cells, Cultured; D003470:Culture Media; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology*; D007111:Immunity, Cellular; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D009108:Mumps Vaccine; D012507:Sarcoidosis / Q000276:immunology*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000946:Antigens, Fungal; D000956:Antigens, Viral; D003470:Culture Media; D007106:Immune Sera; D037102:Lectins; D009108:Mumps Vaccine; D014316:Tritium; D013936:Thymidine